Evaluation of the Diagnostic Performances of the SD-Bioline<sup>®</sup>HBeAg Rapid Test Used Routinely for the Management of HBV-Infected Individuals in Burkina Faso

Evaluation of the Diagnostic Performances of the SD-Bioline<sup>®</sup>HBeAg Rapid Test Used Routinely for the Management of HBV-Infected Individuals in Burkina Faso

Hepatitis B e antigen (HBeAg) is a marker of wild-type hepatitis B virus replication. In resource-limited countries where access to enzyme-linked immunosorbent assay (ELISA) remains a challenge, rapid diagnostic tests (RDT) constitute a good alternative. The HBeAg status is employed to evaluate elig...

Full description

Bibliographic Details
Main Authors: Abdoulaye Dera, Armel M. Sanou, Mathuola N. G. Ouattara, Abdoul K. Ilboudo, David B. Lankoande, Dieudonné Ilboudo, Delphine Napon-Zongo, Michel K. Gomgnimbou
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Diagnostics
Subjects:
hepatitis B
HBeAg
rapid diagnostic test
ELFA
Burkina Faso
Online Access:https://www.mdpi.com/2075-4418/13/19/3144

Internet

https://www.mdpi.com/2075-4418/13/19/3144

Similar Items